Final results from the TITAN-RCC trial demonstrate improvements in objective response rates compared with nivolumab monotherapy.
Cefepime-enmetazobactam may be more effective than piperacillin-tazobactam in treating complicated UTI and acute pyelonephritis caused by organisms that produce extended-spectrum β-lactamases (ESBL), investigators suggested.
However, pulse wave velocity not associated with chronic kidney disease progression
Glargine, liraglutide modestly more effective for target glycated hemoglobin levels; microvascular outcomes do not differ materially
SSBs associated with increased mortality for colorectal, kidney cancers, even after adjustment for BMI
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Both potassium binders effectively lowered serum potassium levels in patients on hemodialysis meeting hyperkalemia definitions, compared with no treatment, investigators reported.
Researchers used data from the ACR RISE registry to evaluate a treat-to-target approach among patients with gout receiving urate-lowering therapy.
Fewer compliance events seen with apixaban versus enoxaparin for extended-duration VTE prophylaxis after abdominopelvic oncologic surgery
Risk increased progressively with the number of autoimmune diseases present and with younger age